Searchable abstracts of presentations at key conferences in endocrinology

ea0044p152 | Neuroendocrinology and pituitary | SFEBES2016

Development of an interactive patient database for the University Teaching Hospital Trust’s neuroendocrine tumour service; and auditing early baseline biochemical investigations for gastroenteropancreatic neuroendocrine tumours

Boylan Joseph , Botchey Sally-Ann , Ahmad Aftab , Ahmad Mahmud

Background: The University Teaching Hospital Trust has a regional neuroendocrine tumour (NET) service that requires a database exclusively for NET patient information. UK and Ireland NET Society (UKINETS) guidelines for gastroenteropancreatic (GEP) NETs recommend plasma Chromogranin-A (Cg-A) and 24 h urinary 5-hydroxyindoacetic acid (24 h Ur 5-HIAA) as baseline investigations. This audit investigated both guideline adherence and the value of these tests in making the diagnosis...

ea0044p53 | Bone and Calcium | SFEBES2016

Importance of bone mineral density care in transitional endocrine service

Yogeswaran Karunya , Ahmad Aftab

Background: The principal cause for increased osteoporosis risk in young adults is the underlying endocrine condition that can severely compromise the prime bone building stage occurring during adolescence. As this could lead to a diminished quality of life from a relatively early stage, emphasis lies on correcting the endocrine condition with appropriately tailored management that can prevent its deterioration. Examples of treatments include replacing deficit hormones such as...

ea0056gp256 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Are Thyrotropin Receptor Antibodies (TRAb) being used to diagnose the aetiology of hyperthyroidism?

Desmond Chloe , Ahmad Aftab

Introduction: Hyperthyroidism is a prevalent condition which affects approximately 2% of the female population and 0.2% of the male population in the UK. 75% of cases are caused by the auto-immune condition, Graves’ disease. Thyrotropin receptor antibodies (TRAb) are raised in 90% of patients with Graves’ disease and are commonly used to investigate the aetiology of thyrotoxicosis.Background: TRAb can be used to confirm Graves’ disease due...

ea0059ep50 | Clinical practice, governance & case reports | SFEBES2018

Bronchial carcinoid presenting as Cushing’s syndrome: A challenging diagnostic conundrum

Wen Yap Yew , Ahmad Aftab , Sharma Dushyant

Introduction: Localising the aetiology of Cushing’s syndrome can be challenging, especially when investigations utilised are limited in their sensitivities and specificities. We present a case whereby the reliabilities of laboratory and radiological investigations are tested to their limits.Case Presentation: A 70 year old female presented with a one year history of fatigue, weight gain and headaches. She had proximal myopathy, cheek telangiectasia ...

ea0044p43 | Bone and Calcium | SFEBES2016

The influence of gender on the bone health of adolescent patients with hormonal deficiencies

Whittingham Pauline , Grounds Kerrie , Ahmad Aftab , Didi Mo , Corlett Pamela

Introduction: Previous audits demonstrated low bone mineral density (BMD) in adolescent patients with hormone deficiencies. We wanted to ascertain if gender had any relationship with the development of low BMD.Method: A retrospective analysis of 42 Transitional clinic patients who underwent DEXA scanning was made using case notes and hospital systems. Follow-up data was gathered as previous audit of 25 transitional patients had shown a significant number...

ea0044p76 | Clinical biochemistry | SFEBES2016

Time taken for GH-treated adolescent patients, transitioning to adult services, to reach IGF1 levels within the upper normal range: Do we need to monitor more frequently?

Grounds Kerrie , Whittingham Pauline , Didi Mo , Ahmad Aftab

Introduction: According to NICE: adults receiving growth hormone (GH) treatment, IGF1 levels should reach therapeutic range by 9 months. Patients are reviewed at 1, 3, 6, 9, 12 months and 6 months thereafter in our clinics. GH dose is titrated by 0.1 mg each visit. This work aims to compare the time it takes to get the IGF1 in range, between adults and adolescent patients attending our specialist regional clinics.Method: We performed a retrospective audi...

ea0034p12 | Bone | SFEBES2014

The influence of gender on the bone health of adolescent patients with hormonal deficiencies

Grounds Kerrie , Corlett Pamela , Ahmad Aftab , Whittingham Pauline

Introduction: Previous audits demonstrated low bone mineral density (BMD) in adolescent patients with hormone deficiencies. We wanted to ascertain if gender had any relationship with the development of low BMD.Method: A retrospective analysis of 42 transitional clinic patients who underwent DEXA scanning was made using case notes and hospital systems. Follow-up data was gathered as previous audit of 25 transitional patients had shown a significant number...

ea0034p193 | Nursing practise | SFEBES2014

Time taken for GH-treated adolescent patients, transitioning to adult services, to reach IGF1 levels within the upper normal range: do we need to monitor more frequently?

Grounds Kerrie , Didi Mohammed , Corlett Pamela , Whittingham Pauline , Ahmad Aftab

Introduction: According to NICE: adults receiving GH treatment, IGF1 levels should reach therapeutic range by 9 months. Patients are reviewed at 1, 3, 6, 9, 12 months and 6 months thereafter in our clinics. GH dose is titrated by 0.1 mg each visit. This work aims to compare the time it takes to get the IGF1 in range, between adults and adolescent patients attending our specialist regional clinics.Method: We performed a retrospective audit of 20 patients ...

ea0031p104 | Clinical practice/governance and case reports | SFEBES2013

Ectopic thyroid tissue presenting as metastatic follicular cancer

Ahmed Syed H , Kalathil Dhanya , Ahmad Aftab , Purewal Tejpal

We present the case of a 73-year-old woman, who presented with ascites and a history of left radical hemithyroidectomy for localized follicular thyroid carcinoma (FTC) 28 years ago. Computed tomography (CT) scanning of her body revealed extensive metastatic lesions. An omental biopsy showed features suggestive of thyroid follicular epithelial cancer. Serum thyroglobulin was raised at 127 μg/l. She died before the biopsy result was received. Two years before presentation, ...

ea0021p6 | Bone | SFEBES2009

Bone mineral density in transitional endocrine clinic in a UK Teaching Hospital

Sreemantula Gayatri , Iqbal Cherakkattil , Didi Mohammed , Ahmad Aftab

Introduction: Endocrinopathies can cause secondary osteoporosis and little is known of the extent of this condition in young adults.Methods: In order to assess the bone health in endocrinopathies in young adults, a retrospective analysis of 25 transitional clinic patients who underwent dual energy X-ray absorptiometry (DEXA scan) was made using case notes and the hospital database.Results: Twenty-three patients were male and the me...